Compliance with GLPs is often a regulatory requirement for the approval of new drugs, chemicals, and other substances. Regulatory bodies like the FDA and European Medicines Agency (EMA) rely on GLP-compliant studies to assess the safety and efficacy of substances. Non-compliance can lead to rejection of study data, delaying product approval and market entry.
